ADX-50938

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameADX-50938

Drug Alias NameCDPPBMetabotropic glutamate receptor-5 modulators - AddexResearch programme: metabotropic glutamate receptor 5 modulators - Addex TherapeuticsADX63365 (mGluR5 positive allosteric modulator [PAM])mGluR5 modulators - Addex +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists

TargetsMetabotropic glutamate receptor 5

Therapy Area/IndicationsSchizophreniaCognition DisordersAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAddex Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAddex Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsSchizophreniaCognition DisordersAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A